Could We Prevent Rheumatoid Arthritis Before It Starts?
This clip is from our "Go With Us!" to EULAR 2025 series. To sign up for our next "Go With Us!" program, visit zurl.co/jTkGK
🎥 Watch the full video here --> zurl.co/n56ft
#AiArthritis #RheumatoidArthritis #EULAR2025
Blog post announcement about key takeaways from EULAR 2025 in regards to Still's Disease.
New insights. New hope. 💜
The latest updates in Still’s disease research are reshaping how we understand diagnosis, treatment, and care — bringing us closer to better outcomes for patients of all ages.
Learn what’s new.
🔗zurl.co/x3WVj
#StillsDisease #AiArthritis #StillsLungDisease #EULAR2025
Why Severity Matters in Choosing Your Treatment | In this clip, learn how severity can determine treatment effectiveness.
This clip is from our "Go With Us!" to EULAR 2025 series. To sign up for our next "Go With Us!" program, visit zurl.co/zzDAn
#TreatmentOptions #PatientEducation #EULAR2025
Infographic showing the top 3 podcast episodes from the AiArthritis Voices 360 Talk Show. Features Episodes 106 on Undifferentiated Disease, 108 on Neurological Symptoms in Lupus and Sjogren's, and 111 on EULAR 2025 Research Updates.
What episode was your favorite in 2025? Let us know in the comments! In 2025, we hosted 12 episodes on topics that matter most to the AiArthritis disease community. To listen, visit zurl.co/cevIr
#AiArthritis #UndifferentiatedDisease #Lupus #SjogrensDisease #EULAR2025 #ChronicIllness #HealthPodcast
Rheumatologists can’t ignore hypereosinopilic syndrome anymore, not when it borders on our diseases and therapies. Great takeaways on subtypes and therapies from Giacomo Emmi in an elegant talk #EULAR2025
buff.ly/lAS7D8u
EULAR Classification criteria for hemachromatosis, presented by Prof. Kiely shows clinical pearls in diagnosis - Hook osteophytes @MCP 2/3, & Iron Fist sign w/ elevation of MCPs 2&3. #EULAR2025
⌛Time is running out! EULAR Congress On-Demand will only be available until 31 December 2025!
Make sure to revisit your favourite sessions or explore anything you haven't had time for yet 👉 https://pulse.ly/9j2gdoxdxj
Catch up while you still can during these final days!
#EULAR2025
From #EULAR2025 - In a large database analysis, use of #GLP1 receptor agonists was associated with a reduced symptom burden in people with #fibromyalgia, but further studies with validated outcome measures are needed.
👉 buff.ly/SB9PQPS
#MedNews
✨ Discover EULAR 2025 Congress meets Education!
EULAR is thrilled to launch new interactive learning modules for free, featuring highlighted WIN and HOT sessions from #EULAR2025.
🎓 The first session is now live! Start your learning journey today with Dr. Sara Monti 👉 https://pulse.ly/nmruwcfuxs
Could one treatment reset the immune system? 🤔
At #EULAR2025, researchers shared groundbreaking updates on CAR-T cell therapy, a single approach showing promise for long-term remission in autoimmune diseases like lupus and scleroderma.
Read more ➡️ www.aiarthritis.org/car-t-eular2...
😨 Did you miss our #EULAR2025 debrief webinar?
😮💨 Don't worry! You can watch the full session at your convenience.
Catch up on all the insights shared by many of the presenters, as well as some of our volunteers and PAN members, on our YouTube channel!
https://www.youtube.com/watch?v=bGy1H9OA-h0
Really pleased to hear that our #EULAR2025 symposium was covered by the European Medical Journal (EMJ)
A Podcast with all the speakers in the session, including Prof Gerd Burmester covering mechanisms of methotrexate use wrt vaccines and me covering the Lungs 🫁!
lnkd.in/en6vw26j
Dr Eve Smith stood on the stage at the EULAR Conference holding a certificate of her award, with those presenting the award stood on either side.
🆕 | @uofgsii.bsky.social Clinical Senior Lecturer in Paediatric Rheumatology Dr Eve Smith has received the prestigious @eular.org Abstract Award – FOREUM: Clinical Science at this year’s #EULAR2025 Congress in Barcelona.
👉 More on this achievement: www.gla.ac.uk/schools/infe...
NEW in our August issue—We highlight some of the exciting research developments presented at #EULAR2025 bit.ly/4kYeWeu
😨 Did you miss our #EULAR2025 debrief webinar?
😮💨 Don't worry! You can watch the full session at your convenience.
Catch up on all the insights shared by many of the presenters, as well as some of our volunteers and PAN members, on our Facebook page!
www.facebook.com/LupusEurope/...
Ich habe die EDS-Session bei #EULAR2025 eröffnet – 5 Minuten über mein Leben mit Ehlers-Danlos.
Komplettes Video (EN UT + DE Übersetzung): youtu.be/D4r_w8y5mFg
Mehr: www.karina-sturm.com
I opened the EDS session at #EULAR2025 with a 5-min speech about living with Ehlers-Danlos Syndrome.
Full video (EN captions + DE translation): youtu.be/D4r_w8y5mFg
More: www.karina-sturm.com
Missed a session or want to revisit the highlights of #EULAR2025?
📺Access the On-Demand Congress Platform and relive from inspiring Scientific Sessions to the unforgettable Opening Ceremony 👉 https://pulse.ly/zbo1z5cmph
🗓️ Available from Monday 16 June until 31 December 2025
#Rheumatology
🌟Thank you to all who attended our #EULAR2025 debrief webinar!
🙌 Especially to our presenters, volunteers & PAN members who shared their insights & experiences.
Stay tuned for more news and updates & don't forget to subscribe to our newsletter! https://www.lupus-europe.org/emails/
⏰ Just 1 hour left for our #EULAR2025 highlights webinar!
😨You haven't registered yet? Don't worry! We have great news for you!
✅ You can still catch all the insights live on our Facebook page https://f.mtr.cool/bufczmhaky
Join us at 18h CET to explore some key takeaways from the Congress!
👏 Don’t miss the new WORKWELL Digital toolkit: www.workwelluk.org
#HealthInnovation #EULAR2025 #RheumatologyResearch #InflammatoryArthritis #WORKWELL #ResearchExcellence #AcademicCollaboration #WorkplaceHealth #DigitalHealth #CMHW #PatientCenteredResearch #HealthInnovation
🎉 Huge congratulations to Prof Yeliz Prior & the #WORKWELL team from @salforduni.bsky.social on winning a Health Professionals Abstract Award at #EULAR2025 @eular.org!
Their WORKWELL trial tackled job retention in #InflammatoryArthritis 💼
🔗 www.salford.ac.uk/news/salford...
#WorkplaceHealth
www.the-rheumatologist.org/article/rheu...
#AYR #APLAR #exchangingprogram #EULAR2025 #Rheumsky
🌟Our #EULAR2025 highlights webinar is tomorrow!
👨⚕️Some of the presenters will share the main takeaways from their talks.
🦋Also, some of our volunteers and PAN members will share their insights from the Congress.
Don’t miss this opportunity!
Register now by ✉️ secretariat@lupus-europe.org
🎥 #EULAR2025 is On-demand!
Watch the interview with Prof. Daniel Aletaha, recorded just after the #EULAR2025 Opening Plenary!
He reflects on his presidency, shares thoughts on the new #myEULAR membership, and gives us a glimpse into what’s next.
Interview here 👉 https://pulse.ly/rti5xdrnyt
❓️Is early intensive therapy with combination csDMARDs or TNFi superior to standard step care for the treatment of moderate to severe #psoriatic_arthritis?
🅰️ Yes
🔅Check out the SPEED RCT presented by @DrLauraCoates at #EULAR2025
OP0089
@RheumNow
#Strategy
🎩REGENCY: Obinutuzumab + standard therapy improved renal outcomes in #lupus nephritis across all tested response definitions (REGENCY, BLISS-LN, AURORA-1). Week 76 CRR consistently 13–16% higher vs placebo. Results hold despite variable thresholds.
@RheumNow #EULAR2025 #OP0006
What happens in pre-RA when you stop #abatacept after 1 yr Rx
At 6 yrs approx 60% on #Placebo
V
50% who initially got #ABA
Prolonged damped effect of development of #RA
NNT for 1 yr is ~10 with a range as low as 6
#EULAR2025 @RheumNow @eular_org
Abst#OP0004 buff.ly/M9TEJum
Can IL-17F signalling be modulated by treatment with TNFi?
In PsA pts non responders to previous TNFi, there was increased expression of IL17F-related gene signature. Suggesting a potential mechanism for the consistent level of clinical response observed with BKZ.
Abstract #OP0091 #EULAR2025
First FcRn inhibitor in #IIM: In #ALKIVIA, SC efgartigimod PH20 improved TIS vs placebo at 24wks (50.45 vs 35.65, p=0.0004), with faster time to TIS≥20 (30 vs 71.5d) & TIS≥40 (113d vs NE). More major responders too (TIS>60: 34% vs 9.5%).
#EULAR2025 #OP0002